The Use of Food and Drug Administration -- Approved Medications for Unlabeled (Off-Label) Uses: The Legal and Ethical Implications
Archives of Dermatology. 1994 Jan; 130(1): 32-36.
Autonomy; Beneficence; Consent; Disclosure; Drug Labeling; Drugs; Federal Government; Food; Government; Government Regulation; Health; Health Insurance; Health Insurance Reimbursement; Informed Consent; Insurance; Investigational Drugs; Legal Aspects; Legislation; Labeling; Patient Care; Physicians; Regulation; Research; Risks and Benefits; Therapeutic Research;
Showing items related by title, author, creator and subject.
Financial Disclosures of Scientific Papers Presented at the 2003 RSNA Annual Meeting: Association With Reporting of Non-Food and Drug Administration-Approved Uses of Industry Products Brown, Stephen D.; Daly, Jennifer C.; Kalish, Leslie A.; McDaniel, Samuel A. (2006-06)